SPRUCE BIOSCIENCES, INC. 8-K — AI Bull & Bear Analysis

The 8-K filing confirms the ratification of the company's auditor and the election of its board, but the voting margins highlight a divide in investor sentiment. While the company has maintained its structural leadership, the advisory vote on compensation and the specific dissent against certain directors indicate a need for improved shareholder alignment. Investors are now weighing the benefit of a stable, experienced board against the red flags of internal governance disputes as the company continues to burn cash to fund its clinical development.